title: Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Buenz
mesh_terms: D000375:Aging; D015897:Comorbidity; D020275:Guillain-Barre Syndrome / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics* / Q000627:therapeutic use; D007155:Immunologic Factors / Q000191:economics* / Q000627:therapeutic use; D008875:Middle Aged; D010951:Plasma Exchange / Q000009:adverse effects / Q000191:economics*; D012720:Severity of Illness Index
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors